Tuesday, July 28, 2020

Atomo Diagnostics and Access Bio partner to expand access to COVID-19 blood-based rapid testing in North America

SYDNEY, July 28, 2020 /PRNewswire/ -- Atomo has announced that it has signed a binding agreement with US-based diagnostics specialist Access Bio Inc. (KOSDAQ: 950130) (Access Bio) that will see Atomo supply its unique, integrated rapid diagnostic test (RDT) devices to Access Bio for use...



from PR Newswire: https://ift.tt/3glWwUJ

No comments:

Post a Comment